To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

DRUG PRICING

TODAY'S HEADLINES

Hearing ups pressure on drugmakers' prices

When the House Committee on Oversight and Government Reform met on January 26, legislators took a closer look at price hikes from companies such as Valeant Pharmaceuticals and Turing Pharmaceuticals. Read more

High-dose insulin pen hits market

Eli Lilly & Company finally releases a high-dose insulin pen, which will help cut down on medication errors associated with the U-100 Humulin insulin pens. Read more

CONTINUING PHARMACY EDUCATION

LAW: Primer on biosimilar agents

This month's CE activity is open for pharmacists and pharmacy technicians, "LAW: Primer on biosimilar agents." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE law credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

FDA approves new indication for Hib vaccine

FDA has approved an expanded age indication for Hib vaccine (Hiberix, GlaxoSmithKine). Details

January 29, 2016

Related Articles

Cancer drug prices not linked to survival rates

Older diabetic patients often overprescribed

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us